European Journal of Dermatology
MENUShort-term effect and safety of a new generation of monoclonal antibodies targeting interleukin-23p19 for treatment of psoriasis: a systematic review and meta-analysis Volume 29, numéro 3, May-June 2019
Citer cet article
Citation de l'article, à la forme « Vancouver » :
Min Hou, Haiyan Xing, Yongqing Cai, Xianfeng Wang, Zhaolu Xie, Qing Zhang, Yunqi Ma, Jianhong Chen. Short-term effect and safety of a new generation of monoclonal antibodies targeting interleukin-23p19 for treatment of psoriasis: a systematic review and meta-analysis. European Journal of Dermatology. 2019;29(3):302-314. doi:10.1684/ejd.2019.3553